Teladoc Health Inc (TDOC) concluded trading on Thursday at a closing price of $7.17, with 4.99 million shares of worth about $35.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -32.93% during that period and on June 12, 2025 the price saw a loss of about -3.37%. Currently the company’s common shares owned by public are about 175.34M shares, out of which, 173.63M shares are available for trading.
Stock saw a price change of 3.46% in past 5 days and over the past one month there was a price change of -5.91%. Year-to-date (YTD), TDOC shares are showing a performance of -21.12% which decreased to -32.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.35 but also hit the highest price of $15.21 during that period. The average intraday trading volume for Teladoc Health Inc shares is 5.29 million. The stock is currently trading 0.50% above its 20-day simple moving average (SMA20), while that difference is up 0.10% for SMA50 and it goes to -19.89% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 175.34M outstanding shares and institutions hold larger chunk of about 73.74% of that.
The stock has a current market capitalization of $1.26B and its 3Y-monthly beta is at 1.79. It has posted earnings per share of -$5.93 in the same period. It has Quick Ratio of 1.61 while making debt-to-equity ratio of 1.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 2.20% while standing at 2.56% over the month.
Analysts are in expectations that Teladoc Health Inc (TDOC) stock would likely to be making an EPS of -0.3 in the current quarter, while forecast for next quarter EPS is -0.23 and it is -0.9 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.36 which is -0.25 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.27 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 80.40% while it is estimated to increase by 22.22% in next year. EPS is likely to grow at an annualized rate of 46.21% for next 5-years, compared to annual growth of -33.66% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
